ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the launch of ResQ215B, a Phase 2 ...
Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...
Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain ...
A new study led by researchers at the UNC School of Medicine and Cartesian Therapeutics, found that immunotherapy can help ...
A first clinical study suggests allogeneic CD19-targeted CAR-T cell therapy can safely induce durable remission in patients with severe, treatment-refractory systemic lupus erythematosus.
At Liv Hospital, specialists emphasize that stem cell therapy isn’t a one-size-fits-all solution. Instead, it is carefully indicated for specific diseases, patient profiles, and treatment ...
Doctors on Saturday welcomed the Supreme Courts order against the use of stem cell therapy to treat autism -- a ...
The Supreme Courts latest ban on the use of stem cell therapy for autism serves as a vital reminder that miracle cures often ...
Supreme Court rules stem cell therapy for autism not clinically viable, citing lack of evidence and calls for regulatory ...
Experts welcomed the SC move as they believed that private labs were minting money from patients on 'false promises'.
The Supreme Court has ruled that stem cell therapy cannot be offered as a treatment for Autism Spectrum Disorder, calling its use outside approved clinical trials unethical and medical malpractice.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results